Refine by
Blood And Transferrin Combo Test Kit Suppliers & Manufacturers
4 companies found
based inXiamen, CHINA
InTec is a world leader in infectious disease diagnostics with a focus on screening at the point of care. In 2017, we delivered over 400 million tests to healthcare professionals around the world, and we strive for continual improvement through ...
INTENDED USE: The kit is intended to qualitatively detect ABO blood group system A/B antigen and Rh blood group system D antigen in fresh finger prick blood/ anticoagulated venous whole blood. Human blood contains a wide variety of blood groups, of ...
based inGeleen, NETHERLANDS
Promicol was established in 2000, founded on many years of experience in all aspects of ATP technology. We are based in The Netherlands, centrally located in Europe, with excellent transport facilities and logistic services. We provide systems that ...
The SANYGO whole blood assay provides a rapid test platform for analysis of the measurement of ATP release, which is used to identify patients who may be at risk for platelet based bleeding or thrombotic complications. The current technology in ...
based inEncino, CALIFORNIA (USA)
Since 1986, Jant Pharmacal has supplied U.S. and international lab and diagnostic practice settings with Point of Care (POC) diagnostic tests, laboratory instrumentation, reagents and consumables. Our highly trained staff’s key focus is on our ...
The Accutest Immunological Fecal Occult Blood Test is a rapid, qualitative, sandwich immunoassay for the determination of fecal occult blood in human stool sample by laboratories or physician offices. It is useful to determine gastrointestinal (GI) ...
based inHillsboro, OREGON (USA)
Diabetomics, Inc. is a global, commercial stage medical diagnostics company pioneering innovative, non-invasive point-of-care tests that are especially useful in alleviating the substantial economic and public health burden of maternal health and ...
The Lumella® Test, The New Point-of-Care Blood Test Helps in Early Detection of Preeclampsia; The Lumella® test estimates the concentration of Glycosylated Fibronectin, a new pregnancy specific biomarker to accurately assess the risk of ...
